The vesamicol receptor ligand (+)-meta-[125i]iodobenzyltrozamicol {(+)-[125i]-mibt} reveals blunting of the striatal cholinergic response to dopamine d2 receptor blockade in the 6-hydroxydopamine (6-ohda)-lesioned rat: Possible implications for Parkinson's disease

Simon M.N. Efange, Rosemary B. Langason, Anil B. Khare, Walter C. Low

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint Dive into the research topics of 'The vesamicol receptor ligand (+)-meta-[<sup>125</sup>i]iodobenzyltrozamicol {(+)-[<sup>125</sup>i]-mibt} reveals blunting of the striatal cholinergic response to dopamine d2 receptor blockade in the 6-hydroxydopamine (6-ohda)-lesioned rat: Possible implications for Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds